Absolute counts of CD3+, CD4+ and CD8 + T lymphocytes have been proposed as a potential predictor of outcome in severe COVID-19 patients38 with an increase in numbers of these cells observed during recovery. The gene discussed is CD8A; the disease is COVID-19.